ossm-001
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2022 (NCT05407766)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05443464 | Phase 1 | Jun 5, 2023 | Ossium Health, Inc. |
| NCT05407766 | Phase 1 | Aug 31, 2022 | Ossium Health, Inc., The Cleveland Clinic |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ossium Health, Inc. | Academic/Hospital | 2 | 2 | 1 | 2022 |
| The Cleveland Clinic | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1